1876FL |
Drug Screen - Expanded, Fluid |
2143B |
Gabapentin, Blood |
2143SP |
Gabapentin, Serum/Plasma |
2143U |
Gabapentin, Urine |
8031U |
Child Drug Exposure Screen, Urine |
8043B |
Postmortem, Prescription Screen w/Vitreous Alcohol, Blood (Forensic) |
8052FL |
Postmortem, Expanded, Fluid (Forensic) |
8052TI |
Postmortem, Expanded, Tissue (Forensic) |
8062FL |
Postmortem, Expanded w/o Alcohol, Fluid (Forensic) |
8062TI |
Postmortem, Expanded w/o Alcohol, Tissue (Forensic) |
8092B |
Postmortem, Prescription Drugs Screen, Blood (Forensic) |
8092FL |
Postmortem, Prescription Drugs Screen, Fluid (Forensic) |
8092SP |
Postmortem, Prescription Drugs Screen, Serum/Plasma (Forensic) |
8092TI |
Postmortem, Prescription Drugs Screen, Tissue (Forensic) |
8092U |
Postmortem, Prescription Drugs Screen, Urine (Forensic) |
8098B |
Drug Screen (GC/MS), Blood |
8098SP |
Drug Screen (GC/MS), Serum/Plasma |
8098U |
Drug Screen (GC/MS), Urine |
9145UC |
Comprehensive Drug Screen, Umbilical Cord Tissue Overview: Detection of in utero exposure to drugs of abuse consistent with maternal use during the second and third trimesters of pregnancy; Newborn (neonatal) toxicology |